Matt Davidson
Chief Development Officer at Adial Pharmaceuticals Inc
Sits on 1 board. Last updated September 28, 2026
Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 3 months
- Director since
- 2026
3 months of board service in total across 1 board, counting each seat separately. Longest: Adial Pharmaceuticals Inc, 3 months.
Adial Pharmaceuticals Inc
Director · Chief Development Officer
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 12, 2026 | Adial Pharmaceuticals Inc | Grant or award | +232,417 | — | — |
| Jun 11, 2026 | Adial Pharmaceuticals Inc | Grant or award | +61,647 | — | — |
| Jun 11, 2026 | Adial Pharmaceuticals Inc | Grant or award | +3,427 | — | — |
| Jun 11, 2026 | Adial Pharmaceuticals Inc | Grant or award | +1,822 | — | — |
| Jun 11, 2026 | Adial Pharmaceuticals Inc | Grant or award | +101 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.